93 related articles for article (PubMed ID: 26002833)
1. Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registry.
Rubboli A; Calabrò P; Saia F; Sciahbasi A;
J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):520-1. PubMed ID: 26002833
[No Abstract] [Full Text] [Related]
2. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
Rubboli A; Saia F; Sciahbasi A; Bacchi-Reggiani ML; Steffanon L; Briguori C; Calabrò P; Palmieri C; Rizzi A; Imperadore F; Sangiorgi GM; Valgimigli M; Carosio G; Steffenino G; Galvani M; Di Pasquale G; La Vecchia L; Maggioni AP; Bolognese L;
J Invasive Cardiol; 2014 Nov; 26(11):563-9. PubMed ID: 25363997
[TBL] [Abstract][Full Text] [Related]
4. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
[No Abstract] [Full Text] [Related]
5. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
Singh PP; Singh M; Bedi U; Molnar J; Arora R; Khosla S
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):23-31. PubMed ID: 21183532
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
[TBL] [Abstract][Full Text] [Related]
9. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
[TBL] [Abstract][Full Text] [Related]
10. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C
Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828
[TBL] [Abstract][Full Text] [Related]
11. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
Nguyen MC; Lim YL; Walton A; Lefkovits J; Agnelli G; Goodman SG; Budaj A; Gulba DC; Allegrone J; Brieger D;
Eur Heart J; 2007 Jul; 28(14):1717-22. PubMed ID: 17562671
[TBL] [Abstract][Full Text] [Related]
12. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
13. In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.
Rubboli A; Sciahbasi A; Briguori C; Saia F; Palmieri C; Moroni LA; Calabrò P; Leone AM; Franco N; Valgimigli M; Varani E; Santi M; Pasqualini P; Capecchi A; Piccalò G; Margheri M; di Pasquale G; Galvani M; Bolognese L; Gonzini L; Maggioni AP;
J Invasive Cardiol; 2013 Apr; 25(4):170-6. PubMed ID: 23549489
[TBL] [Abstract][Full Text] [Related]
14. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
15. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
[TBL] [Abstract][Full Text] [Related]
16. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
17. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of drug-eluting stents in patients on warfarin treatment.
Annala AP; Karjalainen PP; Biancari F; Niemelä M; Ylitalo A; Vikman S; Porela P; Airaksinen KE
Ann Med; 2012 May; 44(3):271-8. PubMed ID: 21208149
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
Gao F; Zhou YJ; Wang ZJ; Yang SW; Nie B; Liu XL; Jia de A; Yan ZX
Int J Cardiol; 2011 Apr; 148(1):96-101. PubMed ID: 21185095
[TBL] [Abstract][Full Text] [Related]
20. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
Buresly K; Eisenberg MJ; Zhang X; Pilote L
Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]